Macular holes stage 2 | Macular holes stage 3 | Macular holes stage 4 | |||||||
---|---|---|---|---|---|---|---|---|---|
Phako-PPV | PPV | P Value | Phako-PPV | PPV | P Value | Phako-PPV | PPV | P Value | |
Mean BCVA preoperatively in LogMAR (±SD) | 0.60 (±0.28) | 0.59 (±0.20) | 0.918† | 0.69 (±0.28) | 0.76 (±0.26) | 0.132† | 0.95 (±0.47) | 0.90 (±0.30) | 0.800† |
Mean BCVA end of follow-up in LogMAR (±SD) | 0.39 (±0.22) | 0.31 (±0.19) | 0.340† | 0.46 (±0.22) | 0.51 (±0.33) | 0.435† | 0.45 (±0.17) | 0.49 (±0.16) | 0.597† |
P Value: BCVA preoperatively vs. end of follow-up | <0.001‡ | 0.003‡ | <0.001‡ | <0.001‡ | 0.002‡ | 0.002‡ |